Cambrian BioPharma Inc

CIK 1797409 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Cambrian BioPharma Inc.

Recent SEC filings

FiledFormAccession number
Aug 11, 20261440001959173-26-005879
Jul 15, 2026D0000950172-26-000183
Jun 1, 202640000897069-26-001299
Apr 29, 20261440001959173-26-003128
Dec 10, 202540000897069-25-001795
Dec 8, 202540000897069-25-001776
Dec 4, 20251440001959173-25-007513
Dec 4, 20251440001959173-25-007516
May 23, 202540001415889-25-014485
Jan 13, 2025D/A0000897069-25-000101
Jun 13, 202440001415889-24-016699
Dec 22, 2023D0000897069-23-001843
Aug 4, 2023SC 13G/A0000897069-23-001093
Aug 2, 202340000897069-23-001054
Jul 12, 202340001209191-23-042076
Mar 7, 20234/A0001567619-23-004608
Feb 14, 2023SC 13G/A0000897069-23-000105
Feb 13, 2023SC 13G/A0000897069-23-000094
Jun 14, 202240001567619-22-012842
Jun 10, 20224/A0001567619-22-012646
Jun 10, 2022SC 13G/A0000897069-22-000414
Apr 21, 20224/A0001567619-22-008798
Apr 21, 20224/A0001567619-22-008800
Mar 2, 202240001567619-22-006007
Mar 1, 202240001567619-22-005913